Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationDiagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia
- Where
- Shanghai
- Age
- 18 years to 85 years
- People
- 600
- Run by
- Changhai Hospital
See details and how to joinNCT06984055 - Phase 2Not yet taking people in ChinaNode-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 176
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06980389 - No phaseNot yet taking people in ChinaThe Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
- Where
- Kunming
- Age
- 18 years to 80 years
- People
- 150
- Run by
- Yunnan Cancer Hospital
See details and how to joinNCT06977386 - Phase 2Not yet taking people in ChinaActive Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 164
- Run by
- Zhigang Li
See details and how to joinNCT06861894 - Phase 2Not yet taking people in ChinaThe Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06965829 - Phase 1/2Taking peopleXELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 57
- Run by
- West China Hospital
See details and how to joinNCT06742411 - Phase 2Not yet taking people in ChinaA Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 42
- Run by
- Zhongguang Luo, MD
See details and how to joinNCT06957977 - No phaseEnrolling by invitationAI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
- Where
- Shijiazhuang
- Age
- 18 years to 80 years
- People
- 1,200
- Run by
- Qun Zhao
See details and how to joinNCT06957678 - No phaseTaking peopleA Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Huashan Hospital
See details and how to joinNCT06300879 - Phase 2Not yet taking people in ChinaEndoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 15
- Run by
- Zhongguang Luo, MD
See details and how to joinNCT06759233 - No phaseEnrolling by invitationRadiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
- Where
- Shijiazhuang
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Qun Zhao
See details and how to joinNCT06947096 - Phase 3Not yet taking people in ChinaA Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 616
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06944496 - No phaseTaking peopleRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
- Where
- Hangzhou, Nanchang, Shanghai
- People
- 600
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06822413 - No phaseTaking peopleReal-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
- Where
- Shenyang
- Age
- 18 years and over
- People
- 120
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06940102 - Phase 3Taking peopleNeoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Lanzhou
- Age
- 18 years to 75 years
- People
- 682
- Run by
- Zuoyi Jiao
See details and how to joinNCT06925243 - Phase 2Taking peopleBenmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
- Where
- Hangzhou, Shanghai, Shantou, Shenyang, Tianjin
- Age
- 18 years and over
- People
- 100
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06637163 - Phase 2Taking peopleA Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 34
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06843889 - No phaseTaking peopleProspective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
- Where
- Hong Kong
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06926374 - Phase 2Taking peopleA Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 34
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06685887 - No phaseEnrolling by invitationAssociation of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Yongxu Jia
See details and how to joinNCT06923020 - No phaseTaking peopleComparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 250
- Run by
- Fujian Medical University
See details and how to joinNCT03716089 - No phaseTaking peopleMetabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
- Where
- Xining
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Qinghai Red Cross Hospital
See details and how to joinNCT06915389 - Phase 2/3Taking peopleOptimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 120
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06907602 - Phase 2Not yet taking people in ChinaToripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 190
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT06903871 - Phase 1/2Enrolling by invitationEvaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
- Where
- Jinan
- Age
- 18 years and over
- People
- 100
- Run by
- Man Hu
See details and how to joinNCT06690216